Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.
about
Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.New considerations in the design of clinical trials for the treatment of acute leukemia.New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation.BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia.The role of early molecular predictor in transplant-eligible chronic myelogenous leukemia.Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
P2860
Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Prediction of relapse by day 1 ...... for chronic myeloid leukemia.
@en
Prediction of relapse by day 1 ...... for chronic myeloid leukemia.
@nl
type
label
Prediction of relapse by day 1 ...... for chronic myeloid leukemia.
@en
Prediction of relapse by day 1 ...... for chronic myeloid leukemia.
@nl
prefLabel
Prediction of relapse by day 1 ...... for chronic myeloid leukemia.
@en
Prediction of relapse by day 1 ...... for chronic myeloid leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Prediction of relapse by day 1 ...... n for chronic myeloid leukemia
@en
P2093
Macintyre E
Vernant JP
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404170
P577
2006-05-01T00:00:00Z